An updated systematic review and meta-analysis of randomized controlled trials on duration of chemotherapy for advanced non-small cell lung cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.8104 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 8104-8104

Author(s):

Yu Yang Soon ◽

Martin R. Stockler ◽

Lisa Askie ◽

Michael J. Boyer

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled

Download Full-text

Thymosin plus cisplatin with vinorelbine or gemcitabine for non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled trials

Thoracic Cancer ◽

10.1111/j.1759-7714.2011.00057.x ◽

2011 ◽

Vol 2 (4) ◽

pp. 213-220 ◽

Author(s):

Jin Jiang ◽

Xiaojing Wang ◽

Jinhui Tian ◽

Lun Li ◽

Qiao Lin

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled

Download Full-text

Effectiveness and safety of chemotherapy with cytokine-induced killer cells in non–small cell lung cancer: A systematic review and meta-analysis of 32 randomized controlled trials

Cytotherapy ◽

10.1016/j.jcyt.2018.10.011 ◽

2019 ◽

Vol 21 (2) ◽

pp. 125-147 ◽

Author(s):

ZHENG XIAO ◽

CHENG-QIONG WANG ◽

JI-HONG FENG ◽

MING-HUA ZHOU ◽

YU-ZHI WANG ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled

Download Full-text

The benefits and risks of CTLA4 inhibitor plus PD1/PDL1 inhibitor in stage IIIB/IV non‐small cell lung cancer: A systematic analysis and meta‐analysis based on randomized controlled trials

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.13465 ◽

2021 ◽

Author(s):

Qiangyun Liu ◽

Zige Fang ◽

Miaowen Liu ◽

Ruoxin Xu ◽

Fengming Yi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Controlled Trials ◽

Small Cell Lung ◽

Systematic Analysis ◽

Randomized Controlled

Download Full-text

Risk profile of bevacizumab in patients with non-small cell lung cancer: A meta-analysis of randomized controlled trials

Acta Oncologica ◽

10.3109/0284186x.2011.631579 ◽

2011 ◽

Vol 51 (2) ◽

pp. 151-156 ◽

Author(s):

Chao Cao ◽

Jianmiao Wang ◽

Hansvin Bunjhoo ◽

Yongjian Xu ◽

Huijuan Fang

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Risk Profile ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled

Download Full-text

The Impact of Afatinib on Survival in Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials

Journal of Cancer ◽

10.7150/jca.27528 ◽

2019 ◽

Vol 10 (4) ◽

pp. 885-892

Author(s):

Chi Wang ◽

Yun Li ◽

Li Ke ◽

Lejie Cao ◽

Pingsheng Fan ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled ◽

Download Full-text

Clinical efficacy and safety of sodium cantharidinate plus chemotherapy in non-small-cell lung cancer: A systematic review and meta-analysis of 38 randomized controlled trials

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.12761 ◽

2018 ◽

Vol 44 (1) ◽

pp. 23-38 ◽

Author(s):

Zheng Xiao ◽

Chengqiong Wang ◽

Zhouke Tan ◽

Shanshan Hu ◽

Yali Chen ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Randomized Controlled

Download Full-text

Maintenance erlotinib improves clinical outcomes of unresectable advanced non-small cell lung cancer: A meta-analysis of randomized controlled trials

Experimental and Therapeutic Medicine ◽

10.3892/etm.2012.690 ◽

2012 ◽

Vol 4 (5) ◽

pp. 849-858 ◽

Author(s):

JIAN ZHANG ◽

WEIQING ZHANG ◽

SHAOHONG HUANG ◽

HUI LI ◽

YUN LI ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Clinical Outcomes ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled

Download Full-text

Comparison between cisplatin plus vinorelbine and cisplatin plus docetaxel in the treatment of advanced non-small-cell lung cancer: A meta-analysis of randomized controlled trials

Molecular and Clinical Oncology ◽

10.3892/mco.2013.210 ◽

2013 ◽

Vol 2 (1) ◽

pp. 146-150 ◽

Author(s):

GUODONG SHEN ◽

GENG BIAN ◽

HAIYING YU ◽

MIN GAO ◽

DONGMEI KANG ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled

Download Full-text

Cetuximab-based Therapy is Effective in Chemotherapy-naïve Patients with Advanced and Metastatic Non-small-cell Lung Cancer: A Meta-analysis of Randomized Controlled Trials

Lung ◽

10.1007/s00408-011-9286-3 ◽

2011 ◽

Vol 189 (3) ◽

pp. 193-198 ◽

Author(s):

Ezzeldin M. Ibrahim ◽

Khaled M. Abouelkhair ◽

Osama A. Al-Masri ◽

Najeeb C. Chaudry ◽

Ghieth A. Kazkaz

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled

Download Full-text

Risk of adverse events with bevacizumab addition to therapy in advanced non-small-cell lung cancer: a meta-analysis of randomized controlled trials

OncoTargets and Therapy ◽

10.2147/ott.s96156 ◽

2016 ◽

pp. 2421 ◽

Author(s):

Han Yang ◽

Xi-Xi Lai ◽

Ren-Ai Xu ◽

Yu-Ping Li

Keyword(s):

Lung Cancer ◽

Adverse Events ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled

Download Full-text